Dr. Daniel Cesar Barzana, DO

Dr. Barzana practices at Wilmington Health in Wilmington, North Carolina.

Dr. Barzana's NPI, 1720280845, was assigned on June 1, 2007. Dr. Barzana holds North Carolina license 140935.

Dr. Barzana's primary practice is Wilmington Health, at 1202 Medical Center Dr, Wilmington, NC 28401 in New Hanover County. The practice phone is (910) 341-3300.

Dr. Barzana's primary practice is Wilmington Health in Wilmington, North Carolina. Dr. Barzana is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Wilmington Health. Dmand AI also links Dr. Barzana to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barzana practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Barzana's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Barzana is licensed in North Carolina.

CMS data shows 1,579 Medicare services from Dr. Barzana across 22 procedure codes in 2024, for 1,198 Medicare patients. Medicare paid $131,145 for them.

CMS counts 1,198 Medicare patients who saw Dr. Barzana in 2026. The largest group is 75 to 84, with 493 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barzana's median patient age at 74, with 46% women.

In 2026, Dr. Barzana wrote 143 Medicare Part D claims for 72 patients. 83% of them were for generic drugs. CMS names the drug for 108 of them, across 3 drugs with 11 or more claims each, at $12,966 in total drug cost. In 2023, CMS named 101 claims across 4 drugs.

Dr. Barzana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 30 procedures of leg revascularization (restoring blood flow) by Dr. Barzana, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Barzana in 2022. Dr. Barzana's most frequent co-authors are Thomas V. Clancy, MD, Dale D. Coffey, DO and Cyrus A. Kotwall, MD.

CMS Open Payments shows 361 general payments to Dr. Barzana from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Medtronic, Inc. paid the most, $2,321.